Novartis drug Afinitor wins EU nod to treat breast cancer

ZURICH (Reuters) - Novartis said on Monday European regulators approved Afinitor to treat women with a certain type of breast cancer, following a panel backing in June.

via Reuters: Health News Read More Here..